Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

26
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
26
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

23
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
23
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

813
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
813
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

36
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Hypertension I: Introduction01:28

Hypertension I: Introduction

37
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
37
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

2.2K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracing the Pen: Electronic Health Records Amid the Rise of Generative AI.

NPJ digital medicine·2026
Same author

Changes in Clinician Time Expenditure and Visit Quantity With Adoption of Artificial Intelligence-Powered Scribes: A Multisite Study.

JAMA·2026
Same author

Protocol for a pragmatic trial comparing navigator and automated virtual interventions for guaranteeing adherence to fecal immunochemical testing (NAVIGATE-FIT).

Contemporary clinical trials communications·2026
Same author

A BEACON for Novel Disease Threats: Leveraging Artificial Intelligence for Informal Event-Based Outbreak Surveillance.

The Journal of infectious diseases·2025
Same author

Generative AI in Health Care-Is Faster Better?

JAMA network open·2025
Same author

Hybrid Ambient Clinical Documentation and Physician Performance: Work Outside of Work, Documentation Delay, and Financial Productivity.

Journal of general internal medicine·2025

Related Experiment Video

Updated: Aug 8, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Personalized hypertension treatment recommendations by a data-driven model.

Yang Hu1, Jasmine Huerta2, Nicholas Cordella2

  • 1Department of Electrical and Computer Engineering, Division of Systems Engineering, Boston University, 8 Saint Mary's St., Boston, MA, 02215, USA.

BMC Medical Informatics and Decision Making
|March 1, 2023
PubMed
Summary
This summary is machine-generated.

This study developed a data-driven model for personalized hypertension treatment, significantly reducing systolic blood pressure (SBP) more than standard care. The approach offers improved medication recommendations for better cardiovascular health management.

Keywords:
Clinical decision supportHypertension prescriptionMachine learning

More Related Videos

Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry
07:54

Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry

Published on: May 17, 2016

20.7K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

216

Related Experiment Videos

Last Updated: Aug 8, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K
Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry
07:54

Long-term Blood Pressure Measurement in Freely Moving Mice Using Telemetry

Published on: May 17, 2016

20.7K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

216

Area of Science:

  • Cardiovascular Medicine
  • Artificial Intelligence in Healthcare
  • Pharmacogenomics

Background:

  • Hypertension is a widespread cardiovascular disease with serious long-term health consequences.
  • Current clinical guidelines for hypertension management lack personalization, failing to incorporate diverse patient characteristics.
  • Personalized treatment approaches are needed to optimize hypertension management.

Purpose of the Study:

  • To develop a data-driven model for personalized hypertension treatment.
  • To recommend antihypertensive medication classes tailored to individual patient characteristics.
  • To improve systolic blood pressure (SBP) reduction compared to standard-of-care.

Main Methods:

  • Utilized de-identified patient records (n=42,752) from Boston Medical Center (2012-2020) with hypertension diagnoses or criteria.
  • Developed predictive models using outlier-immunized regression and nearest neighbor analysis to group patients.
  • Predicted future SBP under different medication classes for each patient to select optimal treatment.

Main Results:

  • The proposed model achieved an average SBP reduction of 14.28 mmHg, outperforming standard-of-care by 70.30%.
  • The model demonstrated superior performance compared to ordinary least squares regression models.
  • Clinician review confirmed that 87.71% of model-generated prescription recommendations were clinically sound.

Conclusions:

  • A data-driven approach significantly enhances personalized hypertension treatment over standard-of-care.
  • The model shows potential for computational deprescribing and supports clinical decision-making in uncertain situations.
  • This personalized strategy offers a promising advancement in managing hypertension.